Goldman Sachs’s Steris STE Stock Holding History

Goldman Sachs’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,800	Closed	-$1.46M	–	5639
2018 Q3	$1.46M	Buy	+12,800	New	+$1.45M	﹤0.01%	3802
2017 Q1	–	Sell	-12,800	Closed	-$863K	–	6993
2016 Q4	$863K	Buy	+12,800	New	+$868K	﹤0.01%	4583
2016 Q3	–	Sell	-5,000	Closed	-$344K	–	7180
2016 Q2	$344K	Buy	+5,000	New	+$350K	﹤0.01%	5222

Other funds holding STE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Goldman Sachs's STE Position: Q2 2026 in Review

Goldman Sachs increased its Steris (STE) stake by 257% in Q2 2026, buying an estimated $210M and bringing the position to 1,363,145 shares worth $287M. The position accounts for 0.02% of the portfolio, ranked #613.

Goldman Sachs first reported a position in STE in Q2 2013 and has held it in 53 quarters since. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

Goldman Sachs held 1,363,145 shares of Steris worth $287M as of Q2 2026.
Goldman Sachs bought 981,568 Steris shares in Q2 2026, an estimated $210M.
Steris made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #613 holding.
Goldman Sachs first reported a position in Steris in Q2 2013 and has held it in 53 quarters since.
839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.